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The epidemiology of non-seminomatous germ cell tumours in the west of
Scotland 1975-89
M Harding, D Hole and C Gillis
West ofScotland Cancer Surveillance Unit, Ruchill Hospital, BilslandDrive, Glasgow G20 9NB, UK.
Summary A total of 438 males resident in the six West of Scotland Health Board areas were notified to the
cancer registry with a diagnosis of teratoma between 1 January 1975 and 31 December 1989. Non-registration
was between 2% and 3.4%; a further 44 cases were ascertained through independent listings in the major
tertiary referral centres. There were four (1%) duplicate registrations and 16 (4%) were incorrect on the basis
of pathology (three) or residence (13). Of these, most (26) were registered with alternative diagnoses and eight
were registered on the pre-1985 manual system. The positive correlation between socioeconomic status and
incidence was confirmed by linking residential postcode at diagnosis to the Carstairs and Morris Deprivation
Index. There was an increasing incidence, both overall and for men aged 15-44 years, with doubling times of
20 and 25 years respectively. The increase was confined to men resident in the more deprived postcode sectors;
the incidence rate among men from the most affluent areas remained unchanged throughout the period of
study.
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Testicular cancer is the only adult cancer whose incidence is
rising and mortality falling, following the introduction of
effective treatment for advanced disease in the 1970s (Oster-
lind, 1986; Boyle et al., 1987).
Both social class and occupation are associated with tes-
ticular cancer. Comparisons between the social class of
patients and geographically defined population denominators
suggest that the incidence of testicular cancer is higher than
expected in the upper social classes (Nethersell and Sikora,
1984; Thornhill et al., 1988). Most occupational differences
achieve levels of statistical significance but the odds ratios are
generally unimpressive and confidence intervals wide. Fur-
thermore, no occupational risk group has been consistently
identified; higher than expected rates are reported in sales
and services workers, doctors, production supervisors and
motor mechanics (Pearce et al., 1987), administrators,
managers, sales workers, professional and allied workers
(Swerdlow and Skeet 1988), teachers and the legal profession
(Thornhill et al., 1988).
An alternative classification of socioeconomic status is
available in Scotland - the Carstairs and Morris Index of
Deprivation (Carstairs and Morris 1991), derived from 1981
census data. Each postcode sector is assigned a deprivation
score based on the difference between the sector and the
Scottish average for male unemployment, proportions ofpeo-
ple in households overcrowded, without a car and headed by
persons in social classes IV and V. Sectors are aggregated
into one of seven categories from 1, the least, to 7, the most
deprived.
Well-recognised risk factors for testicular cancer include
cryptorchidism (Henderson et al., 1979; Schottenfeld et al.,
1980; Pottern et al., 1985; Swerdlow et al., 1987; UK Tes-
ticular Cancer Study Group, 1994) and inguinal hernia (Pot-
tern et al., 1985; Swerdlow et al., 1987; UK Testicular Cancer
Study Group, 1994). There is controversy as to whether early
surgical intervention for these conditions reduces risk of
subsequent malignancy (Pottern et al., 1985; Pike et al.,
1986); although the largest study suggests that correction of
maldescent before the age of 10 years probably does (UK
Testicular Cancer Study Group, 1994). Lack of data on the
population prevelance of cryptorchidism and inguinal hernia
means that estimates of absolute risk are not available, and
the role of surgery in risk reduction is unquantifiable.
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Other potential risk factors include vasectomy (Strader et
al., 1988; Cale et al., 1990), trauma (Morris Brown et al.,
1987) and mumps orchitis (Swerdlow et al., 1987).
As part of an observational study of non-seminomatous
germ cell tumours diagnosed in residents of the West of
Scotland between 1975 and 1989 we have been able to docu-
ment the epidemiology of this subtype of testicular cancer
locally.
Methods
All cases of first non-seminomatous germ cell tumours
(NSGCTs) [defined by ICD-0 morphology codes M 9070 2,
9080 3, 9100 2 and/or site (testis) 186.0-186.9], diagnosed
between 1 January 1975 and 31 December 1989 in males
resident in the six West of Scotland Health Board areas (total
population 2.7 million in 1991), were supplied by the West of
Scotland Cancer Registry. To ensure as complete case ascer-
tainment as possible, disease-specific lists based on ICD-0 site
code 186 or pathology (NSGCT) in the three main tertiary
referral centres were also used.
Diagnosis was verified from the clinical record. Data
abstracted included dates of birth and diagnosis, address or
postcode of residence, family history of testicular cancer,
history of testicular maldescent, inguinal hernia or vasec-
tomy, with dates of surgical intervention when available.
Expected numbers of cases for postcode sectors were cal-
culated by applying the age-specific incidence rates for
NSGCT in the West of Scotland for the period 1975-89 to
the population of each postcode sector as recorded at the
1981 census. Observed and expected numbers of cases were
aggregated over postcode sectors according to their depriva-
tion category grouping. Significance levels and confidence
intervals were calculated, based on an assumed Poisson dist-
ribution.
Testing for trends in NSGCT incidence over time was
carried out by fitting a linear regression model. Probability
values were based on the statistical significance of the regres-
sion equation gradient.
Results
The cancer registry provided 438 names of males with a
diagnosis of NSGCT. Eight were children (median age 15.5
months, range 7-31 months), who are not considered further
in view of the small size of this discrete subgroup. There wereNSGCT in west of Scodand
M Harding etal
four duplicate registrations (0.9%) and clinical records
identified 13 cases (3.1%) not resident in the West of Scot-
land at the time of diagnosis; 11 of these migrated to the
West of Scotland after, in some cases several years after,
diagnosis and two were temporary residents. In three cases
(0.7%) an initial registration as NSGCT should have been
altered following review of the pathology which revealed
diagnoses of seminoma, benign teratoma and adenocar-
cinoma from an unknown primary site.
Of the 426 cancer registry cases (excluding the children and
duplicates), 351 (88%) were found in one or more of the
main tertiary referral centre listings. These alternative data
sources also identified 44 additional cases. The 44 cases were
rechecked against the cancer registry database, which showed
that only nine (2%) had escaped registration entirely.
Reasons for non-inclusion in the original cancer registry
listing are shown in Table I. Eight (1.9%) were traced to the
manual registration system which operated before 1 January
1985: their data had not been transferred to the computerised
register: three of these eight men were diagnosed in the final
quarter of 1984. Initial pathology reports of seminoma or
carcinoma, subsequently modified to teratoma, accounted for
22 cases (50%): and four men who were registered as having
pineal (one), mediastinal (one) and retroperitoneal (two)
teratomas, may have been excluded by the site-specific code
(ICD-0 186, testis). There was a single death certificate-only
registration.
Assuming that the tertiary referral centre data sources
would yield similar proportions of registered (351 of 426;
88%) and apparently non-registered cases (88% of 44), we
conclude that we may have missed up to six additional cases.
This would have increased the proportion unregistered from
2% (in Table I) to 3.4%.
The clinical record was available for 442 of 454 cases
(97%). Missing records tended to be for earlier years (1976
n = 2, 1977 n = 3, 1978 n = 2, 1981 n = 1, 1984 n = 1, 1985
n = 1 and 1988 n = 2). During follow-up to the end of 1991,
eight men (1.8% of all 442 cases and 2.3% of the 343
survivors) developed a second testicular tumour in the
remaining testis; a further NSGCT in five and seminoma in
three.
The median age of the 442 men at the time of NSGCT
diagnosis was 28 years (quartiles 23 and 34 years, range
14-68 years). There was no histological verification for 12
TableI Reasons fornon-inclusion of44meninthecomputerisedWest
of Scotland Cancer Registry listing for teratoma
Pathology
Unexplained ISD Seminoma Carcinoma Site
1975-79 4 2 4 5 -
1980-84 1 6 4 5 4
1985-89 4 - 2 2 -
Total 9 8 10 12 4
ISD, The Information Services Division of the Common Services
Agency, which was responsible for the take-on of pre-1985 manual
registry data to the computerised system. There was one death
certificate-only registration, in 1975
cases although 11 had elevated biochemical tumour markers.
Four hundred and sixteen men had testicular masses and 26
men, (5.9%), who presented with metastatic disease in the
absence of any apparent testicular tumour, were considered
to have primary extragonadal NSGCT.
Testicular maldescent was documented in 35 of 442 (7.9%)
records, unilateral in 25 and bilateral in ten. Ten NSGCTs
arose in an uncorrected maldescended testis, 20 in a testis
after orchidopexy, four in the normally descended contra-
lateral testis and in two the diagnosis was of extragonadal
NSGCT. Of the eight men who developed a second testicular
cancer, only one had maldescent - bilateral and uncorrected.
A prior diagnosis of inguinal hernia was documented in 15
records (3.4%). In few case records was there comment
about absence of either testicular maldescent or inguinal
hernia. Twenty-one men (4.8%) were recorded as having
undergone vasectomy, the absence of this operation was
noted only once. The date of vasectomy was documented for
15, in whom the median interval from vasectomy to diag-
nosis of NSGCT was 18 months (quartiles 8 and 38, range
5-100 months); five developed NSGCT within a year of
vasectomy.
At presentation two men gave a family history of a tes-
ticular tumour, no negative family histories were recorded. A
later note was made of five first- or second-degree relatives
with the same diagnosis. In all, five brothers of four patients
and three first cousin pairs were affected. Two of four sibling
and one of three cousin pairs were registered by the West of
Scotland Cancer Registry but only one cousin pair was
treated at the same centre. There was no indication of the
numbers of first- or second-degree male relatives at risk in
these families or in the families of other cases.
Assigning men to a Carstairs and Morris deprivation
category on the basis of their residential postcode confirmed
the inverse association between age-standardised NSGCT
incidence and deprivation (Table II).
The incidence of NSGCT in the west of Scotland increased
during the 15 years 1975-1989 (Figure 1). Regression
analyses predict that the overall and 15-44 year age-specific
incidence will double in 20 and 25 years respectively. Statis-
tically significant rises in incidence have occurred amongst
men from more deprived areas (deprivation categories 3-7).
No increase is apparent among residents of the more affluent
areas (Table III).
Discussion
The estimate of non-registration (2-3.4%) for adult male
NSGCT during the 15 years 1975-89 is identical to that for
childhood cancers between 1971 and 1984 (Hawkins and
Swerdlow, 1992). This compares well with the published
literature, in which non-registration of between 2% and 28%
is reported for adult cancers, depending on the tumour type
(Nwene and Smith, 1982; Mukherjee et al., 1991). Although
inter-registry comparisons are rare, completeness of lym-
phoma registration is estimated to vary from 87% to 96%
(Swerdlow et al., 1993). The mechanism that permitted
erroneous registration of prevalent tumours (11 of 426, 2.6%
Table II The relationship between socioeconomic status and incidence of non-
seminomatous germ cell tumours in the West of Scotland 1975-89
Deprivation
category Standardised 95%
(Carstairs and Number ofCases incidence confidence
Morris) Observed Expected ratio interval
1 (affluent) 33 22.9 144 99-202
2 52 38.9 134 100-175
3 83 79.8 104 83-129
4 84 95.4 88 70-109
5 78 84.2 93 73-116
6 82 72.2 114 90-141
7 (deprived) 30 43.9 68 46-98
X2 for trend P= 0.03.
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Figure 1 Change in the incidence of teratoma, West of Scotland,
1975-89 -*-, All ages; +, 15-44 years.
in this study) is unclear, but of concern; and the extent to
which this occurs can only be determined from comparison
with the clinical record.
There has been a consistent, worldwide, post-war increase
in testicular cancer incidence. In Scotland this increase
predominantly affected NSGCT (Boyle et al., 1987) in con-
trast the the similar rise in both NSGCT and seminoma
documented from the USA (Schottenfeld et al., 1980), Den-
mark (Osterlind, 1986) and Australia (Stone et al., 1991).
Our data, based on as complete and accurate case ascertain-
ment as possible, confirm that the incidence of NSGCT in
the West of Scotland is rising and likely to double in 20-25
years (Figure 1).
Reasons for this increase remain largely unexplained. The
frequency of surgical intervention for testicular maldescent in
the UK has doubled between 1962 and 1981 (Chilvers et al.,
1984). This is assumed to reflect a similar increase in
incidence, but may represent an increase in surveillance and
hence diagnosis, or intervention. Among this west of Scot-
land cohort, nearly one-third of cases with maldescent (11 of
35) had not undergone any attempt at surgical correction, so
the potential for increasing intervention exists. However, only
a minority (< 13%) of cases are associated with maldescent
(Pottern et al., 1985; Swerdlow et al., 1987; Strader et al.,
1988). Recent UK data suggest that lack of the protective
effect of exercise and earlier puberty may be contributory
(UK Testicular Cancer Study Group, 1994).
There is concern that vasectomy may be a risk factor for
testicular cancer, in view of the parallel increase in both, and
circumstantial supportive evidence (Thornhill et al., 1988;
Cale et al., 1990). However, one study attributed the observa-
tion to under-reporting of vasectomy in Roman Catholic
Table III Changes in incidence (average annual rate per 100 000) of
NSGCT over time, by deprivation category
Deprivation
category
(Carstairs and Time period Testfor trend
Morris) 1975-79 1980-84 1985-89 t P
1+2 2.6 3.3 3.0 0.56 NS
3 +4+ 5 1.2 2.3 2.4 3.60 <0.01
6 + 7 1.6 1.7 3.0 2.73 0.02
controls (Strader et al., 1988), and more recent data fail to
support the hypothesis (Neinhuis et al., 1992; UK Testicular
Cancer Study Group, 1994). An interval of less than 1 year
between vasectomy and diagnosis in one-third of men in the
west of Scotland who reported prior vasectomy, suggests
reporting bias in an attempt to explain testicular swelling.
Neither clinical nor epidemiological publications have,
until recently, suggested that testicular cancer may have a
familial tendency. The literature includes anecdotal reports of
134 pairs offirst-degree relatives (quoted from Forman et al.,
1992). Our observation that none of the pairs of first-degree
relatives were treated at the same centre may contribute to
lack of recognition of a familial association. Data from the
UK case-control study indicate that the cumulative risk for
brothers of cases in their first 50 years is 2.2% (Forman et
al., 1992), a figure similar to the crude risk of a second
testicular cancer (1.8% of all cases and 2.6% of survivors in
this study).
The incidence of cancer in Scotland is highest among
residents of the most deprived postcode sectors, although a
few types of cancer are more common in the affluent residen-
tial postcode areas (Carstairs and Morris, 1991); NSGCT
incidence in the west of Scotland is in this latter category.
East Anglia data suggested that seminoma rather than
NSGCT incidence was related to social class (Nethersall and
Sikora 1984), although this observation was based on fewer
patients and occupationally derived social class was not
available for all cases.
Our data further suggest that the observed increase in
NSGCT incidence is confined to men resident in more dep-
rived areas; indeed by 1985-89, no socioeconomic gradient is
apparent (Table III). Additional studies are required to
confirm this finding. It is possible that, if this trend con-
tinues, NSGCT will no longer be associated with higher
socioeconomic status, and may even become a deprivation-
related tumour.
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